FibroGen Shares Positive Results of Phase 2 Trial of Investigational Therapy Pamrevlumab

A Phase 2 trial testing the investigational therapy pamrevlumab (FG-3019) in patients with idiopathic pulmonary fibrosis (IPF) has shown positive and encouraging results, FibroGen, the drug’s developer, announced. In addition, combining pamrevlumab with the FDA-approved IPF therapies Esbriet (pirfenidone) and Ofev (nintedanib) was found to be safe. These results will be…

Medical marijuana is gaining popularity as a complementary medicine to help with many symptoms associated with chronic illnesses. While many people are curious about how marijuana (or cannabis) may help improve their symptoms, they are also reluctant to smoke the substance. However, there are ways that medical marijuana can be administered, including…

According to the Better Health Channel, a chest infection affects either the larger airways or the smaller air sacs of the lungs. Most chest infections are viruses, meaning that the body’s immune system is enough to fight the infection on its own. However, with most bacterial chest infections, antibiotics are needed. Chest…

Three Lakes Partners, a venture philanthropy organization that finances research in idiopathic pulmonary fibrosis (IPF), has launched its $1 million IPF Catalyst Challenge — a competition to fund the most promising ideas in improving quality of life for IPF patients. The challenge is open to nonprofit groups as well as for-profit ventures. The…

Depression is a common problem for patients with pulmonary fibrosis. It makes sense; we are trying to process being diagnosed with this disease, and its effects on us now and in the future. There is so much to handle as we seek treatment, and obtain the services…

According to the COPD Foundation, understanding how the lungs work will help those who suffer from lung diseases have a little bit more control over their breathing. MORE: Seven common symptoms of pulmonary fibrosis. As you inhale, air composed of approximately 21 percent oxygen enters the…

According to the Cystic Fibrosis Foundation, there are seven major airway clearance techniques (ACTs) for patients with lung disease. Airway clearance is needed to help clear away mucus from the lungs to help prevent infections and to improve lung function. Children will need an adult to assist with ACTs, and…

I am still reflecting on an experience I had last week at the grocery store — one that, unfortunately, is common for other patients, too. Several months after being diagnosed with idiopathic pulmonary fibrosis (IPF), I began having to lug around supplemental oxygen. My ability to do…

Researchers at two universities in North Carolina have developed a new method to expand stem cells isolated from patient’s lung biopsies. A team led by Dr. Jason Lobo, assistant professor of medicine at the University of North Carolina (UNC), and by Ke Cheng, associate professor in the Department of Molecular…

Recent studies have shown that idiopathic pulmonary fibrosis (IPF) may be caused by senescence, a cellular aging process. Now, a team of German researchers have successfully counteracted this mechanism in cell culture by using senolytic drugs that are able to kill senescent epithelial lung cells. These findings were reported in a study…